Healthcare
Martek Biosciences Corporation - Financial and Strategic Analysis Review
| Publication Date | June 2009 |
| Publisher | Global Markets Direct |
| Product Type | Report |
| Pages | 19 |
| ISBN Number | not applicable |
| Product Code | GMD02169 |
Summary
Martek Biosciences Corporation - Financial and Strategic Analysis Review
Martek Biosciences Corporation (Martek) is a biotechnology company engaged in the development and commercialization of novel products from microalgae, fungi, and other microbes. The company develops omega-3 docosahexaenoic acid (DHA) products. The company has Life'sDHA, is a vegetarian source of docosahexaenoic acid (DHA) produced from algae and Life'sARA, is a long-chain polyunsaturated omega-6 fatty acid produced from fungus. The company has its operation in more than 75 countries. The company is headquartered in Columbia, Maryland of the United States
Global Markets Direct's Martek Biosciences Corporation - Financial and Strategic Analysis Review is an in-depth business, strategic and financial analysis of Martek Biosciences Corporation. The report provides a comprehensive insight into the company, including business structure and operations, executive biographies and key competitors. The hallmark of the report is the detailed strategic analysis of the company. This highlights its strengths and weaknesses and the opportunities and threats it faces going forward.
Scope
- Provides key company information for business intelligence needs.
- The company's strengths and weaknesses and areas of development or decline are analyzed. Financial, strategic and operational factors are considered.
- The opportunities open to the company are considered and its growth potential assessed. Competitive or technological threats are highlighted.
- The report contains critical company information - business structure and operations, the company history, major products and services, key competitors, key employees and executive biographies, different locations and important subsidiaries.
- The report provides detailed financial ratios for the past five years as well as interim ratios for the last four quarters.
- Financial ratios include profitability, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Reasons to buy
- A quick "one-stop-shop" to understand the company.
- Enhance business/sales activities by understanding customers' businesses better.
- Get detailed information and financial and strategic analysis on companies operating in your industry.
- Identify prospective partners and suppliers - with key data on their businesses and locations.
- Capitalize on competitor's weaknesses and target the market opportunities available to them.
- Compare your company's financial trends with those of your peers / competitors.
- Scout for potential acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.
Contents
- List of Tables
- List of Figures
- Key Facts
- Business Description
- Major Products and Services
- History
- SWOT Analysis
- SWOT Analysis - Overview
- Martek Biosciences Corporation - Strengths
- Martek Biosciences Corporation - Strengths - Strong Financial Performance
- Martek Biosciences Corporation - Strengths - Broad Patent Portfolio
- Martek Biosciences Corporation - Strengths - Sturdy R&D Activities
- Martek Biosciences Corporation - Strengths - Strategic Collaborations
- Martek Biosciences Corporation - Weaknesses
- Martek Biosciences Corporation - Weaknesses - Dependence on Infant Formula Market
- Martek Biosciences Corporation - Weaknesses - Dependence on Limited Number of Customers
- Martek Biosciences Corporation - Opportunities
- Martek Biosciences Corporation - Opportunities - Supply Agreement with Hero
- Martek Biosciences Corporation - Opportunities - Expanding the Use of DHA
- Martek Biosciences Corporation - Opportunities - Emerging Markets
- Martek Biosciences Corporation - Threats
- Martek Biosciences Corporation - Threats - Industry Consolidation
- Martek Biosciences Corporation - Threats - Tightening of FDA's Regulatory Oversight
- Martek Biosciences Corporation - Threats - Competition
- Martek Biosciences Corporation - Threats - Pending Lawsuits
- Key Competitors
- Key Employees
- Key Employee Biographies
- Company Statement
- Locations And Subsidiaries
- Locations And Subsidiaries - Head Office
- Locations And Subsidiaries - Other Locations & Subsidiaries
- Financial Ratios
- Financial Ratios - Capital Market Ratios
- Financial Ratios - Annual Ratios
- Financial Ratios - Interim Ratios
- Financial Ratios - Ratio Charts
- Appendix
- Methodology
- Ratio Definitions
- About Global Markets Direct
- Contact Us
- Disclaimer
- List of Tables
- Martek Biosciences Corporation, Key Facts
- Major Products and Services
- Martek Biosciences Corporation, History
- Martek Biosciences Corporation, Key Employees
- Martek Biosciences Corporation, Key Employee Biographies
- Martek Biosciences Corporation, Other Locations
- Martek Biosciences Corporation, Subsidiaries
- Martek Biosciences Corporation, Ratios based on current share price
- Martek Biosciences Corporation, Annual Ratios
- Martek Biosciences Corporation, Interim Ratios
- Currency Codes
- Capital Market Ratios
- Equity Ratios
- Profitability Ratios
- Cost Ratios
- Liquidity Ratios
- Leverage Ratios
- Efficiency Ratios
- List of Figures
- Martek Biosciences Corporation, Ratio Charts








